AVILA THERAPEUTICS

avila-therapeutics-logo

Avila Therapeutics designs and develops covalent drugs for viral infections, cancers, and autoimmune diseases. It offers AVL-181, a small molecule hepatitis C virus protease inhibitor. Avila Therapeutics has a strategic alliance with Sanofi-Aventis. The company was incorporated in 2006 and is based in Waltham, Massachusetts. As of March 7, 2012, Avila Therapeutics operates as a subsidiary of Celgene Corporation.

#SimilarOrganizations #People #Financial #Website #More

AVILA THERAPEUTICS

Industry:
Biotechnology Health Care Medical

Founded:
2006-01-01

Address:
Waltham, Massachusetts, United States

Country:
United States

Website Url:
http://www.avilatx.com

Total Employee:
11+

Status:
Active

Contact:
781-891-0086

Email Addresses:
[email protected]

Total Funding:
59.28 M USD

Technology used in webpage:
CSC Global DNS CDNS Network


Similar Organizations

aura-biosciences-logo

Aura Biosciences

Aura Biosciences is a biotechnology company that focuses on the development of drugs by using tumor targeted pseudovirions.

cedilla-therapeutics-logo

Cedilla Therapeutics

Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.

madronish-therapeutics-logo

Madronish Therapeutics

Madronish Therapeutics, LLC (MTL) is a biotechnology company focused on immuno-oncology strategies to either enhance immune response.

novellus-logo

Novellus

Novellus is a biotechnology company working to develop engineered cellular medicines.

Current Employees Featured

juswinder-singh_image

Juswinder Singh
Juswinder Singh Co-Founder & Chief Scientific Officer @ Avila Therapeutics
Co-Founder & Chief Scientific Officer

andrew-hirsch_image

Andrew Hirsch
Andrew Hirsch VP, Chief Financial Officer @ Avila Therapeutics
VP, Chief Financial Officer

Founder


juswinder-singh_image

Juswinder Singh

roy-lobb_image

Roy Lobb

Investors List

abingworth-management_image

Abingworth

Abingworth investment in Series B - Avila Therapeutics

advent-venture-partners_image

Advent Venture Partners

Advent Venture Partners investment in Series B - Avila Therapeutics

avila-venture-capital_image

Avila Venture Capital

Avila Venture Capital investment in Series B - Avila Therapeutics

polaris-venture-capital_image

Polaris Venture Capital

Polaris Venture Capital investment in Series B - Avila Therapeutics

novartis-venture-fund_image

Novartis Venture Fund

Novartis Venture Fund investment in Series B - Avila Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series B - Avila Therapeutics

abingworth-management_image

Abingworth

Abingworth investment in Series A - Avila Therapeutics

polaris-partners_image

Polaris Partners

Polaris Partners investment in Series A - Avila Therapeutics

advent-venture-partners_image

Advent Venture Partners

Advent Venture Partners investment in Series A - Avila Therapeutics

atlas-venture_image

Atlas Venture

Atlas Venture investment in Series A - Avila Therapeutics

Official Site Inspections

http://www.avilatx.com

  • Host name: 165.160.13.20
  • IP address: 165.160.13.20
  • Location: United States
  • Latitude: 37.751
  • Longitude: -97.822
  • Timezone: America/Chicago

Loading ...

More informations about "Avila Therapeutics" on Search Engine